FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034278159> ?p ?o ?g. }

• W2034278159 endingPage "202" @default.
• W2034278159 startingPage "196" @default.
• W2034278159 abstract "To evaluate topiramate as monotherapy in adults and children with recently diagnosed, localization-related epilepsy, comparing two dosages of topiramate in a multicenter, randomized, double-blind study.Adults and children (>/=3 years of age) were eligible if the maximum interval since epilepsy diagnosis was 3 years and patients had one to six partial-onset seizures during a 3-month retrospective baseline. At study entry, patients (N = 252) were untreated or receiving one antiepileptic drug for less than 1 month. After randomization to 50 or 500 mg/d topiramate (25 or 200 mg/d if weight </= 50 kg), patients remained in the study until 4 months after the last patient was randomized or until patients met seizure-related exit criteria (e.g., had two seizures). The primary efficacy outcome was a univariate analysis of time-to-exit, which was time to second seizure in 96% of patients.The time-to-exit (median, 422 days vs 293 days) favored the higher dose of topiramate, but this difference was not significant. When time-to-exit was analyzed with time-to-first-seizure as a covariate, the difference between dosage groups was significant (p = 0.01), reflecting the higher seizure-free rates (54% vs 39%, p = 0.02) and longer time-to-first-seizure (median 317 days vs 108 days; p = 0.06) in patients receiving 200 or 500 mg/d topiramate. Higher plasma concentration was associated with increased time-to-first seizure (p < 0.01). Dose-related adverse events included paresthesia, weight loss, diarrhea, and hypoesthesia.Although the primary efficacy analysis was negative, time-to-exit analyses that included time-to-first-seizure as a covariate, between-group differences in seizure-free rates, and longer time-to-first-seizure with higher serum concentration provide evidence that topiramate is effective as monotherapy in patients with localization-related epilepsy." @default.
• W2034278159 created "2016-06-24" @default.
• W2034278159 creator A5008448627 @default.
• W2034278159 creator A5037516355 @default.
• W2034278159 creator A5037632361 @default.
• W2034278159 creator A5050363327 @default.
• W2034278159 creator A5065795125 @default.
• W2034278159 creator A5069330822 @default.
• W2034278159 creator A5074918503 @default.
• W2034278159 creator A5076677796 @default.
• W2034278159 creator A5085356343 @default.
• W2034278159 creator A5085400242 @default.
• W2034278159 date "2003-01-28" @default.
• W2034278159 modified "2023-10-16" @default.
• W2034278159 title "A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy" @default.
• W2034278159 cites W1974311184 @default.
• W2034278159 cites W1974809694 @default.
• W2034278159 cites W1987467897 @default.
• W2034278159 cites W1998338808 @default.
• W2034278159 cites W2007343138 @default.
• W2034278159 cites W2032109763 @default.
• W2034278159 cites W2039674635 @default.
• W2034278159 cites W2040597207 @default.
• W2034278159 cites W2043242122 @default.
• W2034278159 cites W2071500856 @default.
• W2034278159 cites W2083976498 @default.
• W2034278159 cites W2085172751 @default.
• W2034278159 cites W2093392404 @default.
• W2034278159 cites W2095558066 @default.
• W2034278159 cites W2117449343 @default.
• W2034278159 cites W2129745199 @default.
• W2034278159 cites W2171332093 @default.
• W2034278159 cites W2320058521 @default.
• W2034278159 cites W2322086287 @default.
• W2034278159 doi "https://doi.org/10.1212/01.wnl.0000048200.12663.bc" @default.
• W2034278159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12552030" @default.
• W2034278159 hasPublicationYear "2003" @default.
• W2034278159 type Work @default.
• W2034278159 sameAs 2034278159 @default.
• W2034278159 citedByCount "136" @default.
• W2034278159 countsByYear W20342781592012 @default.
• W2034278159 countsByYear W20342781592013 @default.
• W2034278159 countsByYear W20342781592014 @default.
• W2034278159 countsByYear W20342781592015 @default.
• W2034278159 countsByYear W20342781592016 @default.
• W2034278159 countsByYear W20342781592017 @default.
• W2034278159 countsByYear W20342781592018 @default.
• W2034278159 countsByYear W20342781592019 @default.
• W2034278159 countsByYear W20342781592020 @default.
• W2034278159 countsByYear W20342781592021 @default.
• W2034278159 countsByYear W20342781592022 @default.
• W2034278159 countsByYear W20342781592023 @default.
• W2034278159 crossrefType "journal-article" @default.
• W2034278159 hasAuthorship W2034278159A5008448627 @default.
• W2034278159 hasAuthorship W2034278159A5037516355 @default.
• W2034278159 hasAuthorship W2034278159A5037632361 @default.
• W2034278159 hasAuthorship W2034278159A5050363327 @default.
• W2034278159 hasAuthorship W2034278159A5065795125 @default.
• W2034278159 hasAuthorship W2034278159A5069330822 @default.
• W2034278159 hasAuthorship W2034278159A5074918503 @default.
• W2034278159 hasAuthorship W2034278159A5076677796 @default.
• W2034278159 hasAuthorship W2034278159A5085356343 @default.
• W2034278159 hasAuthorship W2034278159A5085400242 @default.
• W2034278159 hasConcept C118552586 @default.
• W2034278159 hasConcept C126322002 @default.
• W2034278159 hasConcept C141071460 @default.
• W2034278159 hasConcept C162156334 @default.
• W2034278159 hasConcept C168563851 @default.
• W2034278159 hasConcept C187212893 @default.
• W2034278159 hasConcept C197934379 @default.
• W2034278159 hasConcept C204243189 @default.
• W2034278159 hasConcept C2775858608 @default.
• W2034278159 hasConcept C2777683783 @default.
• W2034278159 hasConcept C2778186239 @default.
• W2034278159 hasConcept C42219234 @default.
• W2034278159 hasConcept C71924100 @default.
• W2034278159 hasConceptScore W2034278159C118552586 @default.
• W2034278159 hasConceptScore W2034278159C126322002 @default.
• W2034278159 hasConceptScore W2034278159C141071460 @default.
• W2034278159 hasConceptScore W2034278159C162156334 @default.
• W2034278159 hasConceptScore W2034278159C168563851 @default.
• W2034278159 hasConceptScore W2034278159C187212893 @default.
• W2034278159 hasConceptScore W2034278159C197934379 @default.
• W2034278159 hasConceptScore W2034278159C204243189 @default.
• W2034278159 hasConceptScore W2034278159C2775858608 @default.
• W2034278159 hasConceptScore W2034278159C2777683783 @default.
• W2034278159 hasConceptScore W2034278159C2778186239 @default.
• W2034278159 hasConceptScore W2034278159C42219234 @default.
• W2034278159 hasConceptScore W2034278159C71924100 @default.
• W2034278159 hasIssue "2" @default.
• W2034278159 hasLocation W20342781591 @default.
• W2034278159 hasLocation W20342781592 @default.
• W2034278159 hasOpenAccess W2034278159 @default.
• W2034278159 hasPrimaryLocation W20342781591 @default.
• W2034278159 hasRelatedWork W2057743042 @default.
• W2034278159 hasRelatedWork W2061077838 @default.
• W2034278159 hasRelatedWork W2070110219 @default.
• W2034278159 hasRelatedWork W2096168305 @default.

• next